GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » Institutional Ownership

Aelis Farma (XPAR:AELIS) Institutional Ownership : 0.45% (As of Jun. 08, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aelis Farma's institutional ownership is 0.45%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aelis Farma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aelis Farma's Float Percentage Of Total Shares Outstanding is 0.00%.


Aelis Farma Institutional Ownership Historical Data

The historical data trend for Aelis Farma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma Institutional Ownership Chart

Aelis Farma Historical Data

The historical data trend for Aelis Farma can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-04-30 2024-05-31
Institutional Ownership 0.52 0.52 0.48 0.49 0.49 0.49 0.48 0.48 0.45 0.45

Aelis Farma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Aelis Farma (XPAR:AELIS) Business Description

Traded in Other Exchanges
Address
146, rue Leo Saignat, Bordeaux, FRA, 33077
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma (XPAR:AELIS) Headlines

No Headlines